000 | 01799nim a2200421 a 4500 | ||
---|---|---|---|
001 | HST8201 | ||
003 | UkLoHST | ||
006 | m o h | ||
007 | cr nna|||||||| | ||
007 | sr |mnnnnnzne| | ||
008 | 210304s2021 enk|||||o||h||||||||eng d | ||
028 | 5 | 0 |
_a8201 _bHenry Stewart Talks |
035 | _a(UkLoHST)4460 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aKobold, Sebastian, _u(Ludwig-Maximilians-Universität München, Germany) _4spk |
|
245 | 1 | 0 |
_aCAR-T and TCR-T cellular immunotherapies in oncology _h[electronic resource] / _can interview with Sebastian Kobold. |
260 |
_aLondon : _bHenry Stewart Talks, _c2021. |
||
300 | _a1 online resource (1 streaming audio file (20 min.)). | ||
490 | 1 |
_aResearch and clinical interviews, _x2056-452X |
|
500 | _aAudio interview. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: An overview of CAR-T cell therapy -- Introduction to the mode of action of CAR-T cell therapy -- Differences between CAR-T and TCR-T therapies -- Resistance mechanisms to CAR-T cell therapy. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aCancer _xImmunotherapy. |
|
650 | 0 | _aCellular therapy. | |
650 | 0 |
_aT cells _xTherapeutic use. |
|
650 | 2 | _aCell- and Tissue-Based Therapy. | |
650 | 2 | _aImmunotherapy, Adoptive. | |
650 | 2 |
_aNeoplasms _ximmunology. |
|
650 | 2 |
_aNeoplasms _xtherapy. |
|
650 | 2 |
_aReceptors, Antigen, T-Cell _xtherapeutic use. |
|
650 | 2 |
_aReceptors, Chimeric Antigen _xtherapeutic use. |
|
650 | 2 |
_aT-Lymphocytes _ximmunology. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pResearch and clinical interviews. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4460/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1102/ _3Series |
999 |
_c75840 _d75840 |